Abiopharma

🔍 MARTELL RON (Director)

Company: Jasper Therapeutics, Inc. (JSPR)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 234,000 shares of Stock Option (right to buy) at $1.84 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 234,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: 1/4th of the shares subject to the option shall vest on January 2, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.